Toru Ishikawa
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Hepatitis C virus research
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 119
- Hepatocellular Carcinoma Treatment and Prognosis 63
- Hepatitis C virus research 40
- Liver Disease and Transplantation 36
- Epidemiology 101
- Liver Disease Diagnosis and Treatment 85
- Hepatitis B Virus Studies 25
- Co-authors
- Junichi KitajimaYasuko TanakaHidenori ToyodaToshifumi TadaTakashi KumadaKunihiko TsujiAtsushi HiraokaTakafumi Ichida
- Journals
- Chemical and Pharmaceutical Bulletin (28 papers)World Journal of Gastroenterology (15 papers)Hepatology Research (14 papers)Journal of Gastroenterology and Hepatology (10 papers)Phytochemistry (7 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Toru Ishikawa
216 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 139
- Hepatology 1.5k
- Epidemiology 1.2k
- Complementary and alternative medicine 226
- Pharmacology 163
- Cancer Research 266
Countries citing papers authored by Toru Ishikawa
This map shows the geographic impact of Toru Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Ishikawa more than expected).
Fields of papers citing papers by Toru Ishikawa
This network shows the impact of papers produced by Toru Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Ishikawa. The network helps show where Toru Ishikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toru Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 1 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 11 | |
| 12 | 2019 | 31 | |
| 13 | 2019 | 7 | |
| 14 | 2018 | 5 | |
| 15 | 2018 | 149 | |
| 16 | 2018 | 57 | |
| 17 | 2017 | 17 | |
| 18 | 2016 | 22 | |
| 19 | 2016 | 34 | |
| 20 | 2014 | 2 |
About Toru Ishikawa
Toru Ishikawa is a scholar working on Hepatology, Epidemiology, Surgery, Otorhinolaryngology and Gastroenterology, having authored 237 papers that have together received 3.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (85 papers), Hepatocellular Carcinoma Treatment and Prognosis (63 papers), Hepatitis C virus research (40 papers), Liver Disease and Transplantation (36 papers), Hepatitis B Virus Studies (25 papers), Natural product bioactivities and synthesis (23 papers), Phytochemistry and Biological Activities (22 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (1.2k citations), Complementary and alternative medicine (226 citations), Pharmacology (163 citations) and Cancer Research (266 citations). Toru Ishikawa has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Junichi Kitajima, Yasuko Tanaka, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Kunihiko Tsuji, Atsushi Hiraoka, Takafumi Ichida, Yoichi Hiasa and Toshiaki Yoshida. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, World Journal of Gastroenterology, Hepatology Research, Journal of Gastroenterology and Hepatology and Phytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.